BR112020015692A2 - Compostos de pirazol e preparação dos mesmos - Google Patents
Compostos de pirazol e preparação dos mesmos Download PDFInfo
- Publication number
- BR112020015692A2 BR112020015692A2 BR112020015692-2A BR112020015692A BR112020015692A2 BR 112020015692 A2 BR112020015692 A2 BR 112020015692A2 BR 112020015692 A BR112020015692 A BR 112020015692A BR 112020015692 A2 BR112020015692 A2 BR 112020015692A2
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- compound
- alkyl
- haloalkyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/122—Halides of copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201811003855 | 2018-02-01 | ||
| IN201811003855 | 2018-02-01 | ||
| IN201811003859 | 2018-02-01 | ||
| IN201811003859 | 2018-02-01 | ||
| IN201711042921 | 2018-05-30 | ||
| IN201711042921 | 2018-05-30 | ||
| PCT/IN2019/050076 WO2019150392A1 (en) | 2018-02-01 | 2019-02-01 | Pyrazole compounds and preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020015692A2 true BR112020015692A2 (pt) | 2020-12-08 |
Family
ID=67478207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020015692-2A BR112020015692A2 (pt) | 2018-02-01 | 2019-02-01 | Compostos de pirazol e preparação dos mesmos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11873289B2 (https=) |
| EP (1) | EP3746434A4 (https=) |
| JP (1) | JP7402804B2 (https=) |
| KR (1) | KR102951622B1 (https=) |
| CN (1) | CN111670184A (https=) |
| AU (1) | AU2019213854C1 (https=) |
| BR (1) | BR112020015692A2 (https=) |
| CA (1) | CA3090204A1 (https=) |
| IL (1) | IL276410B2 (https=) |
| MA (1) | MA54677A (https=) |
| MX (2) | MX2020008151A (https=) |
| MY (1) | MY209060A (https=) |
| SG (1) | SG11202007328UA (https=) |
| WO (1) | WO2019150392A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3090204A1 (en) | 2018-02-01 | 2019-08-08 | MyoKardia, Inc. | Pyrazole compounds and preparation thereof |
| WO2025244956A1 (en) * | 2024-05-20 | 2025-11-27 | MyoKardia, Inc. | Methods of manufacturing danicamtiv |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284386A (ja) * | 2006-04-18 | 2007-11-01 | Kumiai Chem Ind Co Ltd | ３−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤 |
| US8324178B2 (en) * | 2008-10-31 | 2012-12-04 | The Regents Of The University Of California | Method of treatment using alpha-1-adrenergic agonist compounds |
| EP2714680B1 (en) * | 2011-05-27 | 2015-11-25 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
| BR112015004097B1 (pt) | 2012-08-30 | 2020-02-18 | Bayer Cropscience Ag | Procedimento para a descarboxilação de derivados do ácido 3,5-bis (haloalquil) -pirazol-4-carboxílico |
| CN104968664A (zh) | 2012-12-12 | 2015-10-07 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的并环化合物 |
| EP3063134B1 (en) | 2013-11-01 | 2020-08-12 | Srf Limited | Process for the preparation of pyrazole derivatives |
| EP3015458A1 (en) | 2014-11-03 | 2016-05-04 | Bayer CropScience AG | Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines |
| EP4234017B1 (en) * | 2015-01-22 | 2026-04-15 | MyoKardia, Inc. | Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm) |
| EP3568390B1 (en) * | 2017-01-10 | 2024-03-06 | Sanford Burnham Prebys Medical Discovery Institute | Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof |
| CN111132964A (zh) | 2017-04-11 | 2020-05-08 | 欧瑞克制药公司 | 糖皮质激素受体调节剂 |
| CA3090204A1 (en) | 2018-02-01 | 2019-08-08 | MyoKardia, Inc. | Pyrazole compounds and preparation thereof |
-
2019
- 2019-02-01 CA CA3090204A patent/CA3090204A1/en active Pending
- 2019-02-01 BR BR112020015692-2A patent/BR112020015692A2/pt active Search and Examination
- 2019-02-01 EP EP19747117.0A patent/EP3746434A4/en active Pending
- 2019-02-01 SG SG11202007328UA patent/SG11202007328UA/en unknown
- 2019-02-01 JP JP2020541983A patent/JP7402804B2/ja active Active
- 2019-02-01 MY MYPI2020003963A patent/MY209060A/en unknown
- 2019-02-01 WO PCT/IN2019/050076 patent/WO2019150392A1/en not_active Ceased
- 2019-02-01 US US16/966,502 patent/US11873289B2/en active Active
- 2019-02-01 MA MA054677A patent/MA54677A/fr unknown
- 2019-02-01 CN CN201980011350.9A patent/CN111670184A/zh active Pending
- 2019-02-01 AU AU2019213854A patent/AU2019213854C1/en active Active
- 2019-02-01 MX MX2020008151A patent/MX2020008151A/es unknown
- 2019-02-01 IL IL276410A patent/IL276410B2/en unknown
- 2019-02-01 KR KR1020207022279A patent/KR102951622B1/ko active Active
-
2020
- 2020-07-31 MX MX2025003379A patent/MX2025003379A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3746434A1 (en) | 2020-12-09 |
| IL276410B2 (en) | 2024-09-01 |
| IL276410A (en) | 2020-09-30 |
| MX2020008151A (es) | 2020-09-18 |
| US11873289B2 (en) | 2024-01-16 |
| KR102951622B1 (ko) | 2026-04-13 |
| AU2019213854C1 (en) | 2023-12-14 |
| US20210053940A1 (en) | 2021-02-25 |
| SG11202007328UA (en) | 2020-08-28 |
| MX2025003379A (es) | 2025-05-02 |
| MA54677A (fr) | 2021-11-17 |
| MY209060A (en) | 2025-06-18 |
| KR20200118025A (ko) | 2020-10-14 |
| CA3090204A1 (en) | 2019-08-08 |
| EP3746434A4 (en) | 2021-11-17 |
| AU2019213854B2 (en) | 2023-06-15 |
| JP7402804B2 (ja) | 2023-12-21 |
| CN111670184A (zh) | 2020-09-15 |
| JP2021512127A (ja) | 2021-05-13 |
| AU2019213854A1 (en) | 2020-09-03 |
| WO2019150392A1 (en) | 2019-08-08 |
| IL276410B1 (en) | 2024-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103980098B (zh) | 含二氟甲氧醚桥键（cf2o）的单体液晶化合物的制备方法 | |
| JP4336648B2 (ja) | エポキシトリアゾール誘導体およびその中間体の製造方法 | |
| CN101321522A (zh) | 环氧丁醇中间体的制备方法 | |
| BR112020015692A2 (pt) | Compostos de pirazol e preparação dos mesmos | |
| JP6029090B2 (ja) | フッ素化物の単離方法 | |
| JP3662761B2 (ja) | フェノキシアルキルハライド誘導体の新規製造法 | |
| EP3587410B1 (en) | Method for preparing sultone derivatives | |
| JP2011157292A (ja) | 含フッ素エステル化合物の製造方法、及び多官能含フッ素エステル化合物 | |
| CN115448971B (zh) | 一种用于制备氟维司群的中间体及其制备方法 | |
| TWI452040B (zh) | 光酸發生劑之製造方法 | |
| CN104744378A (zh) | 一种(e)-3-[4-(4-氟苯基)-6-异丙基-2-(n-甲基-n-甲磺酰胺基)嘧啶-5-基]丙烯醛的合成方法 | |
| CA2468426A1 (en) | Process for preparing n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide | |
| JP2021512127A5 (https=) | ||
| HK40027579A (en) | Pyrazole compounds and preparation thereof | |
| EA044890B1 (ru) | Пиразольные соединения и их получение | |
| JPS6220995B2 (https=) | ||
| WO2005026176A1 (ja) | ３−クロロメチル-３-セフェム誘導体の製造方法 | |
| JP4465674B2 (ja) | ベンジル（ジフルオロメチル）スルフィド化合物の製造方法 | |
| JP2009249357A (ja) | １−ビニル−４−［（４−ビニルフェニル）ジスルファニル］ベンゼン誘導体 | |
| JP2001506255A (ja) | チアゾール類の製造 | |
| JP2008189630A (ja) | ４−（置換メチル）シクロヘキサンカルボアルデヒド | |
| JP2531228B2 (ja) | ビフェニル誘導体およびその製造法 | |
| CN117143026A (zh) | 一种杂芳基三氟甲基化合物的合成方法 | |
| DE2432408A1 (de) | 21-chlor-11 beta, 16 alpha, 17 alphatrihydroxypregnen-3,20-dion-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| JP2004115476A (ja) | （ｒ）−３−ハロゲノ−２−メチルプロパノールの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] |